====== NMS-873 0.07μM R07 exp380 ====== ==== Mechanism of Action ==== Inhibits p97 AAA-ATPase * **Class / Subclass 1:** Proteostasis / Ubiquitin-Proteasome Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%CID 71521142%% * **Synonyms:** N/A * **CAS #:** 1418013-75-8 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/71521142|71521142]] * **IUPAC:** %%3-[3-cyclopentylsulfanyl-5-[[3-methyl-4-(4-methylsulfonylphenyl)phenoxy]methyl]-1,2,4-triazol-4-yl]pyridine%% * **INCHI Name:** InChI=1S/C27H28N4O3S2/c1-19-16-22(11-14-25(19)20-9-12-24(13-10-20)36(2,32)33)34-18-26-29-30-27(35-23-7-3-4-8-23)31(26)21-6-5-15-28-17-21/h5-6,9-17,23H,3-4,7-8,18H2,1-2H3 * **INCHI Key:** UJGTUKMAJVCBIS-UHFFFAOYSA-N * **Molecular Weight:** 520.7 * **Canonical SMILES:** CC1=C(C=CC(=C1)OCC2=NN=C(N2C3=CN=CC=C3)SC4CCCC4)C5=CC=C(C=C5)S(=O)(=O)C * **Isomeric SMILES:** N/A * **Molecular Formula:** C27H28N4O3S2 {{:chemogenomics:structures:chem-0227.svg?nolink}} * **Supplier Name:** Ark Pharm Inc. * **Catalog #:** AK175592 * **Lot #:** WG0305592-170215001 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C27H28N4O3S2 521.16756; found 521.16873 * **Platform ID:** NMS-873 * **Min:** 2.2487; **Max:** 99.2142 {{:chemogenomics:dose_response:dr_394.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.0307 | | IC30 |0.0729 | | IC40 |0.1455 | | IC50 |0.2720 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 07 * **Dose**: 70nM * **Days of incubation**: 8 * **Doublings**: 4.2 * **Numbers of reads**: 19956950 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |1/5|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/NMS-873_0.07uM_Round-7_exp380.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp380.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:G:GOT1|GOT1]]|-5.76|<0.01| |[[:human_genes:A:ALDOA|ALDOA]]|-3.13|0.30| |[[:human_genes:R:RSRC2|RSRC2]]|-2.59|0.46| |[[:human_genes:S:SUCLG1|SUCLG1]]|-2.57|0.30| |[[:human_genes:V:VPS25|VPS25]]|-2.47|0.44| |[[:human_genes:S:SUCLA2|SUCLA2]]|-2.40|0.30| |[[:human_genes:M:MSL1|MSL1]]|-2.39|0.30| |[[:human_genes:G:GMPPB|GMPPB]]|-2.35|0.44| |[[:human_genes:A:APOBEC3F|APOBEC3F]]|-2.33|0.30| |[[:human_genes:C:CNOT8|CNOT8]]|-2.28|0.30| |[[:human_genes:E:ENO1|ENO1]]|-2.27|0.30| |[[:human_genes:N:NCLN|NCLN]]|-2.21|0.33| |[[:human_genes:P:PTEN|PTEN]]|-2.18|0.30| |[[:human_genes:I:INTS3|INTS3]]|-2.18|0.44| |[[:human_genes:K:KIDINS220|KIDINS220]]|-2.17|0.30| |[[:human_genes:G:GPI|GPI]]|-2.15|0.50| |[[:human_genes:L:LIPT1|LIPT1]]|-2.13|0.30| |[[:human_genes:H:HK1|HK1]]|-2.11|0.31| |[[:human_genes:G:GIGYF2|GIGYF2]]|-2.10|0.47| |[[:human_genes:S:SOD2|SOD2]]|-2.06|0.44| |[[:human_genes:T:TRADD|TRADD]]|-2.05|0.44| |[[:human_genes:A:AHCYL1|AHCYL1]]|-2.05|0.44| |[[:human_genes:W:WDR20|WDR20]]|-2.02|0.44| |[[:human_genes:M:MED20|MED20]]|-2.00|0.44| |[[:human_genes:C:CCDC101|CCDC101]]|-2.00|0.44| |[[:human_genes:C:CLEC4C|CLEC4C]]|-1.98|0.44| |[[:human_genes:G:GCDH|GCDH]]|-1.96|0.44| |[[:human_genes:C:CXorf51A|CXorf51A]]|-1.95|0.44| |[[:human_genes:Y:YRDC|YRDC]]|-1.95|0.47| |[[:human_genes:C:CXorf51B|CXorf51B]]|-1.94|0.44| |[[:human_genes:W:WARS2|WARS2]]|2.09|0.24| |[[:human_genes:N:NDUFA1|NDUFA1]]|2.11|0.24| |[[:human_genes:C:CTU1|CTU1]]|2.12|0.19| |[[:human_genes:M:MTG1|MTG1]]|2.12|0.24| |[[:human_genes:K:KLF16|KLF16]]|2.12|0.30| |[[:human_genes:C:CLK1|CLK1]]|2.13|0.19| |[[:human_genes:P:PANX3|PANX3]]|2.18|0.24| |[[:human_genes:A:ATP5A1|ATP5A1]]|2.19|0.14| |[[:human_genes:Z:ZNF343|ZNF343]]|2.24|0.19| |[[:human_genes:W:WDR83|WDR83]]|2.24|0.13| |[[:human_genes:F:FAM98B|FAM98B]]|2.26|0.13| |[[:human_genes:F:FOXA3|FOXA3]]|2.29|0.13| |[[:human_genes:G:GFM2|GFM2]]|2.29|0.13| |[[:human_genes:B:BRMS1|BRMS1]]|2.31|0.24| |[[:human_genes:M:MRPS35|MRPS35]]|2.35|0.23| |[[:human_genes:M:MIR205HG|MIR205HG]]|2.39|0.57| |[[:human_genes:S:SHMT2|SHMT2]]|2.40|0.13| |[[:human_genes:P:PTMA|PTMA]]|2.41|0.13| |[[:human_genes:H:HSCB|HSCB]]|2.42|0.08| |[[:human_genes:S:SIN3A|SIN3A]]|2.47|0.24| |[[:human_genes:R:RPS3A|RPS3A]]|2.48|0.14| |[[:human_genes:P:PDS5B|PDS5B]]|2.60|0.05| |[[:human_genes:R:RPL11|RPL11]]|2.60|0.24| |[[:human_genes:A:ATP5B|ATP5B]]|2.70|0.03| |[[:human_genes:A:ATP5L|ATP5L]]|2.73|0.08| |[[:human_genes:I:ITPK1|ITPK1]]|2.79|0.02| |[[:human_genes:A:ATP5D|ATP5D]]|2.83|0.07| |[[:human_genes:C:CCND3|CCND3]]|2.96|0.13| |[[:human_genes:A:ACSL3|ACSL3]]|3.18|<0.01| |[[:human_genes:S:SLC25A51|SLC25A51]]|4.12|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp241|QNZ 0.01μM R05 exp241]]|0.107|| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|0.104|| |[[:results:exp212|Phenformin 20μM R05 exp212]]|0.091|| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|0.088|| |[[:results:exp143|Phenformin 20μM R03 exp143]]|0.051|| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|0.076|| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|0.059|| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|0.052|| {{:chemogenomics:comparison_plots:exp241_vs_exp380.png?nolink |}} {{:chemogenomics:comparison_plots:exp380_vs_exp431.png?nolink |}} {{:chemogenomics:comparison_plots:exp212_vs_exp380.png?nolink |}} {{:chemogenomics:comparison_plots:exp380_vs_exp439.png?nolink |}} {{:chemogenomics:comparison_plots:exp143_vs_exp380.png?nolink |}} {{:chemogenomics:comparison_plots:exp380_vs_exp48.png?nolink |}} {{:chemogenomics:comparison_plots:exp380_vs_exp65.png?nolink |}} {{:chemogenomics:comparison_plots:exp13_vs_exp380.png?nolink |}} ^GO Term^Fold Change^Genes^ |succinate-CoA ligase activity|637.65|SUCLG1,SUCLA2| |glycolytic process|60.73|ALDOA,ENO1,GPI,HK1| |pyruvate metabolic process|38.07|ALDOA,ENO1,GPI,HK1| |carbohydrate catabolic process|23.62|ALDOA,ENO1,GPI,HK1| |glucose metabolic process|21.80|GOT1,ENO1,GPI,HK1| |hexose metabolic process|20.31|GOT1,ALDOA,ENO1,GPI,HK1| |monosaccharide metabolic process|17.14|GOT1,ALDOA,ENO1,GPI,HK1| |generation of precursor metabolites and energy|11.87|ALDOA,SUCLG1,SUCLA2,ENO1,GPI,HK1,SOD2| |oxoacid metabolic process|6.15|GOT1,ALDOA,SUCLA2,ENO1,GPI,LIPT1,HK1,GCDH| |organic acid metabolic process|6.09|GOT1,ALDOA,SUCLA2,ENO1,GPI,LIPT1,HK1,GCDH| ^GO Term^Fold Change^Genes^ |proton-transporting ATP synthase activity, rotational mechanism|157.90|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A| |mitochondrial proton-transporting ATP synthase complex|147.37|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A| |proton-transporting ATP synthase complex|138.16|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A| |proton channel activity|100.48|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A| |proton motive force-driven mitochondrial ATP synthesis|52.14|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |proton motive force-driven ATP synthesis|46.05|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |ATP biosynthetic process|39.47|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |purine ribonucleoside triphosphate biosynthetic process|34.11|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |purine nucleoside triphosphate biosynthetic process|33.70|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |oxidative phosphorylation|33.49|SLC25A51,ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |ribonucleoside triphosphate biosynthetic process|32.13|ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |aerobic respiration|23.52|SLC25A51,ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |ligase activity|20.72|ACSL3,ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,WARS2| |cellular respiration|19.62|SLC25A51,ATP5F1D,ATP5MG,ATP5F1B,ATP5F1A,NDUFA1| |purine-containing compound biosynthetic process|17.50|ACSL3,ATP5F1D,ATP5MG,ATP5F1B,SHMT2,ATP5F1A,NDUFA1| |mitochondrial inner membrane|10.84|SLC25A51,ATP5F1D,ATP5MG,ATP5F1B,SHMT2,MRPS35,ATP5F1A,MTG1,NDUFA1| |organelle inner membrane|9.73|SLC25A51,ATP5F1D,ATP5MG,ATP5F1B,SHMT2,MRPS35,ATP5F1A,MTG1,NDUFA1| |mitochondrial membrane|7.83|SLC25A51,ACSL3,ATP5F1D,ATP5MG,ATP5F1B,SHMT2,MRPS35,ATP5F1A,MTG1,NDUFA1| |mitochondrial envelope|7.35|SLC25A51,ACSL3,ATP5F1D,ATP5MG,ATP5F1B,SHMT2,MRPS35,ATP5F1A,MTG1,NDUFA1|